Initial reports indicated worse outcomes for TB/COVID-19 co-infection when com-pared to each infection.[22] A scoping review by Flores-Lovon et al found host immune responses to be enhanced in patients manifesting COVID-19 and LTBI, with higher COVID-19 specific neutralizing antibodies, absolute lymphocyte counts, and IFN-γ levels. This evidence concerns the gene IFNG and tuberculosis.